Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Most patients on this hepatitis C treatment experienced skin issues, especially hair loss.

Certain alkaloids could help create new coronavirus drugs.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

New compounds show promise as nonsteroidal treatments for hair loss.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Optimizing the structure of a specific compound greatly improved its effectiveness and precision for treating diabetic complications.

GI197111X is best dissolved in Capmul MCM for trials.

The S9 fraction with GC-IDMS is effective for measuring 5α-reductase activity.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Combining immune checkpoint inhibitors with other cancer therapies increases skin side effects in Asian patients.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

New tests detect finasteride and dutasteride in urine quickly and easily.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

The higher dose supplement was more effective in treating female hair loss.

Finasteride may help prevent prostate cancer.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Methyl pyropheophorbide A from Sansevieria trifasciata leaves may help treat hair loss.

Serenoa repens extract shows promise as a natural treatment for prostate cancer.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.